Keyphrases
Acute Administration
16%
Acute Therapy
16%
Atrophy
16%
Beneficial Effects
16%
Bexarotene
100%
Bisphenol A Diglycidyl Ether (BADGE)
16%
Blood-brain Barrier Leakage
16%
Brain Infarct
16%
Cell Polarization
16%
Cerebral Blood Flow
16%
Focal Cerebral Ischemia
16%
Histological Outcome
16%
Immunofluorescence Analysis
16%
Immunomodulatory
16%
Immunomodulatory Effect
16%
Insults
16%
Ipsilateral Hemisphere
16%
Ischemic Condition
16%
Ischemic Stroke
100%
Myeloid Cell Differentiation
16%
Myeloid Cells
16%
N2 Neutrophils
16%
Neurological Deficit
16%
Neuroprotection
100%
Neuroprotective Potential
33%
Neutrophil Polarization
16%
Noninflammatory
16%
Novel Therapeutic Targets
16%
Peripheral Neutrophils
16%
Peroxisome Proliferator-activated Receptor
100%
Receptor Agonist
33%
Receptor Antagonist
33%
Receptor Heteromers
16%
Repurposing
16%
Retinoid X Receptor
100%
Rexinoids
16%
Spleen
33%
Transient Middle Cerebral Artery Occlusion (tMCAO)
50%
Medicine and Dentistry
Acute Drug Administration
16%
Bexarotene
100%
Bisphenol A
16%
Blood Brain Barrier
16%
Brain Blood Flow
16%
Brain Infarction
16%
Brain Ischemia
100%
Cell Differentiation
16%
Diethyl Ether
16%
Hemisphere
16%
Heterodimer
16%
Immunofluorescence
16%
Middle Cerebral Artery Occlusion
50%
Myeloid Cell
33%
Neuroprotection
100%
Neuroprotective Agent
33%
Neutrophil
33%
Peroxisome Proliferator Activated Receptor
100%
Peroxisome Proliferator Activated Receptor Antagonist
16%
Receptor Antagonist
16%
Retinoid X Receptor
100%
Neuroscience
Bexarotene
100%
Blood Brain Barrier
16%
Brain Ischemia
100%
Cellular Differentiation
16%
Immunofluorescence
16%
Middle Cerebral Artery
50%
Myeloid
33%
Neuroprotection
100%
Neuroprotective Agent
33%
Peroxisome Proliferator-Activated Receptor
100%
Receptor Agonists
33%
Receptor Antagonist
33%
Retinoid X Receptor
100%
Pharmacology, Toxicology and Pharmaceutical Science
Bexarotene
100%
Bisphenol A Diglycidyl Ether
16%
Blood-Brain Barrier
16%
Brain Infarction
16%
Brain Ischemia
100%
Heterodimer
16%
Middle Cerebral Artery Occlusion
50%
Neuroprotection
100%
Neuroprotective Agent
33%
Peroxisome Proliferator Activated Receptor
100%
Peroxisome Proliferator Activated Receptor Antagonist
16%
Receptor Agonist
33%
Receptor Antagonist
16%
Retinoid X Receptor
100%